Merck gains EU approval of Keyruda, Padcev combo for bladder cancer

Bulls and bears hash it out on MGM Resorts

2026/08/17

Overvalued? This tech-to-savings ratio flirting with 'extreme' territory

2026/08/17

Dollar falls weekly as softer US data weighs on Fed rate outlook

2026/08/17

3 Software Stocks We Keep Off Our Radar

2026/08/17